Targeting mediators of microhomology-mediated end joining (MMEJ) POLQ and PARP1 (Figure 4A) also had a statistically significant viability reducing and DNA damage increasing effect on the cells supporting the concept of synthetic lethality of POLQ (polymerase theta, Polθ) inhibition in HR deficient cancers [27]. Here, PARP1 is linked to cancer.